Explore more publications!
Healthcare Focus Minnesota
Got News to Share?

Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 4, 2026

HealthRecon Connect Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance
Mar. 4, 2026

HealthRecon Connect Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance

Indeterminate GlobeNewswire
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Mar. 4, 2026

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome

Indeterminate GlobeNewswire
AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER
Mar. 4, 2026

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Indeterminate GlobeNewswire
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
Mar. 4, 2026

Actuate Therapeutics to Present at The Citizens Life Sciences Conference

Indeterminate GlobeNewswire
Sotera Health Announces Secondary Offering of Common Stock
Mar. 4, 2026

Sotera Health Announces Secondary Offering of Common Stock

Indeterminate GlobeNewswire
DBV Technologies to Participate in Upcoming March Investor Conferences
Mar. 4, 2026

DBV Technologies to Participate in Upcoming March Investor Conferences

Indeterminate GlobeNewswire
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars
Mar. 4, 2026

DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars

Indeterminate GlobeNewswire
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
Mar. 4, 2026

Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB

Indeterminate GlobeNewswire
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Mar. 4, 2026

SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
LB Pharmaceuticals to Participate in Upcoming March Investor Events
Mar. 4, 2026

LB Pharmaceuticals to Participate in Upcoming March Investor Events

Indeterminate GlobeNewswire
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
Mar. 4, 2026

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mar. 4, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance
Mar. 4, 2026

Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
Mar. 4, 2026

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

Indeterminate GlobeNewswire
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
Mar. 4, 2026

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

Indeterminate GlobeNewswire
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Mar. 4, 2026

Larimar Therapeutics to Participate in Upcoming Investor Conferences in March

Indeterminate GlobeNewswire
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
Mar. 4, 2026

Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference

Indeterminate GlobeNewswire
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
Mar. 4, 2026

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment

Indeterminate GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America
Mar. 4, 2026

Galapagos Receives Transparency Notifications from Bank of America

Indeterminate GlobeNewswire
Galapagos ontvangt transparantieverklaringen van Bank of America
Mar. 4, 2026

Galapagos ontvangt transparantieverklaringen van Bank of America

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions